VUMC’s Kimryn Rathmell wins Doris Duke Foundation Paragon Award

Vanderbilt receives $1M grant to fund immunotherapy research in CRC

The Robert J. Kleberg Jr. and Helen C. Kleberg Foundation awarded a $1 million grant to support research at Vanderbilt aimed at dramatically expanding the efficacy of immunotherapy for colorectal cancer.

October 04, 2024

Vol.50 No.37

Clinical Roundup

Kidney cancers rely on mitochondrial metabolism to metastasize, UTSW study shows

Research from Children’s Medical Center Research Institute at UT Southwestern shows that metastatic kidney cancers rely heavily on mitochondrial metabolism. These findings are contrary to how tumors operate while still in the kidney.

September 06, 2024

Vol.50 No.33

Clinical Roundup

UTSW study reveals widespread disparities in immunotherapy use for patients with advanced kidney and bladder cancers

A study led by researchers at UT Southwestern Medical Center reveals significant disparities across the country in the use of immunotherapy for patients with advanced kidney and bladder cancers.

September 06, 2024

Vol.50 No.33

Clinical Roundup

Changing gut microbiome improves outcomes for people newly diagnosed with metastatic kidney cancer in phase I study

People with metastatic kidney cancer who orally took a live biotherapeutic product called CBM588 while in treatment with immunotherapy and enzymatic tyrosine kinase inhibitors experienced improved health outcomes, according to research from City of Hope.

July 05, 2024

Vol.50 No.27

Clinical Roundup

Cells in tumor microenvironment play critical role in effectiveness of rapalogs

For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now, a study by researchers at UT Southwestern Medical Center’s Kidney Cancer Program sheds light.

June 14, 2024

Vol.50 No.24

In Brief

Ray Blind named associate director for DEI at Vanderbilt-Ingram

Ray Blind, Ingram Assistant Professor of Cancer Research, was named associate director for diversity, equity, and inclusion at Vanderbilt-Ingram Cancer Center.

April 26, 2024

Vol.50 No.17

VUMC’s Kimryn Rathmell wins Doris Duke Foundation Paragon Award

YOU MAY BE INTERESTED IN

Vanderbilt receives $1M grant to fund immunotherapy research in CRC

Kidney cancers rely on mitochondrial metabolism to metastasize, UTSW study shows

UTSW study reveals widespread disparities in immunotherapy use for patients with advanced kidney and bladder cancers

Changing gut microbiome improves outcomes for people newly diagnosed with metastatic kidney cancer in phase I study

Cells in tumor microenvironment play critical role in effectiveness of rapalogs

Ray Blind named associate director for DEI at Vanderbilt-Ingram

Renew today!

Subscriber content

Never miss an issue!

Login